Skip to content

Rash impulsiveness and reward sensitivity as predictors of treatment outcome in addiction

Rash impulsiveness and reward sensitivity as predictors of treatment outcome in addiction - impulsiveness and reward sensitivity in treatment of addiction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33386
Enrollment
60
Registered
2010-01-18
Start date
2010-02-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

verslaving addiction substance dependence

Interventions

None listed

Sponsors

Erasmus Universiteit Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: male, substance dependent, inpatient in a clinical faclility for the treatment of addiction

Exclusion criteria

Exclusion criteria: severe concomitant interfering psychiatric disorders (acute mood disorders, acute psychotic disorders and neuropsychiatric disorders)

Design outcomes

Primary

MeasureTime frame
drop out from treatment. It is defined as the number of weeks an individual stays at the Rehabilitation section of the inpatient treatment facility. A cut-off score is determined at 30 days and subjects will be assigned to one of two groups. One group will comprise early drop-outs; the other will consist of subjects who persist longer.

Secondary

MeasureTime frame
In addition to the cut-off procedure as described above, retention will be measured as the time to drop-out. By doing so, insight may be acquired in specific patterns of drop out. Third, three months after initial assessment, the alcohol and drug use section of the Addiction Severity Index (ASI)-interview will be administered once again, to investigate the relative change in use of addictive substances. Fourth, during hospitalisation, file inspection will be done to into the results of urine analysis and to keep track of self report of relapse in substance use. These two measures are indicators of treatment succes.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)